Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study
| Autor: | Borg, C. *, André, T., Mantion, G., Boudghène, F., Mornex, F., Maingon, P., Adenis, A., Azria, D., Piutti, M., Morsli, O., Bosset, J.F. |
|---|---|
| Zdroj: | In Annals of Oncology November 2014 25(11):2205-2210 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|